Catalyst Wire Dossier Catalyst Wire Dossier

Remlarsen

MRG-201 · miRagen Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Remlarsen, covering 2021-07-19 to 2021-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids [Phase 2]

See pricing